Strain imaging to detect cancer therapeutics-related cardiac dysfunction: Are we there yet?

Future Cardiology

Volumn 11, Issue 4, 2015, Pages 401-405

  Collier, Patrick ^a   Koneru, Srikanth ^a   Tamarappoo, Balaji ^a   Griffin, Brian ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cancer therapeutics related cardiac dysfunction; Cardio oncology; Echo; Radiation heart disease; Strain

Indexed keywords

ANALYSIS; CANCER THERAPY; HEART DISEASE; HUMAN; IMAGING; NOTE; ONCOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; CARDIAC IMAGING; CARDIOTOXICITY; CARDIOVASCULAR DISEASES; NEOPLASMS;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CARDIAC IMAGING TECHNIQUES; CARDIOTOXICITY; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS;

EID: 84939436396     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/FCA.15.40     Document Type: Note

References (20)

1. Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J. Clin. Oncol. 23, 8597-8605 (2005).
2. Zhang S, Liu X, Bawa-Khalfe T et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat. Med. 18, 1639-1642 (2012).
3. Ewer MS, Lippman SM. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J. Clin. Oncol. 23, 2900-2902 (2005).
4. Lal H, Kolaja KL, Force T. Cancer genetics and the cardiotoxicity of the therapeutics. J. Am. Coll. Cardiol. 61, 267-274 (2013).
5. Hershman DL, McBride RB, Eisenberger A, Tsai WY, Grann VR, Jacobson JS. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. J. Clin. Oncol. 26, 3159-3165 (2008).
6. Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J. Clin. Oncol. 25, 3525-3533 (2007).
7. Wadhwa D, Fallah-Rad N, Grenier D et al. Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study. Breast Cancer Res. Treat. 117, 357-364 (2009).
8. Fallah-Rad N, Lytwyn M, Fang T, Kirkpatrick I, Jassal DS. Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy. J. Cardiovasc. Magn. Reson. 10, 5 (2008).
9. Cardinale D, Colombo A, Lamantia G et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J. Am. Coll. Cardiol. 55, 213-220 (2010).
10. Skovgaard D, Hasbak P, Kjaer A. BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography. PLoS ONE 9, e96736 (2014).
11. Carver JR, Shapiro CL, Ng A et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J. Clin. Oncol. 25, 3991-4008 (2007).
12. Desai MY, Wu W, Masri A et al. Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiationassociated cardiac disease undergoing cardiac surgery. Ann. Thorac. Surg. 97, 1348-1355 (2014).
13. Seicean S, Seicean A, Alan N, Plana JC, Budd GT, Marwick TH. Cardioprotective effect of beta-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure. Circ. Heart Fail. 6, 420-426 (2013).
14. Lancellotti P, Nkomo VT, Badano LP et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur. Heart J. Cardiovasc. Imaging 14, 721-740 (2013).
15. Plana JC, Galderisi M, Barac A et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 27, 911-939 (2014).
16. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovi? ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J. Am. Coll. Cardiol. 61, 77-84 (2013).
17. Negishi K, Negishi T, Hare JL, Haluska BA, Plana JC, Marwick TH. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J. Am. Soc. Echocardiogr. 26, 493-498 (2013).
18. Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J. Am. Coll. Cardiol. 63, 2751-2768 (2014).
19. Erven K, Florian A, Slagmolen P et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 85, 1172-1178 (2013).
20. Cheng S, Larson MG, McCabe EL et al. Reproducibility of speckle-tracking-based strain measures of left ventricular function in a community-based study. J. Am. Soc. Echocardiogr. 26, 1258-1266 e1252 (2013).